Racial disparities in access after regulatory surveillance of benzodiazepines

Archives of Internal Medicine
Sallie-Anne PearsonDennis Ross-Degnan

Abstract

We examined the effects of a prescription-monitoring program on benzodiazepine access among Medicaid enrollees living in neighborhoods of different racial composition. We used interrupted time series and logistic regression to analyze data from noninstitutionalized persons aged 18 years or older (N = 124 867) enrolled continuously in New York Medicaid 12 months before and 24 months and 7 years after initiation of the program. We used census data to identify the racial composition of the neighborhoods. Outcome measures were nonproblematic use (short term, within dosing guidelines), potentially problematic use (>120 days' use or more than twice the recommended dose), and pharmacy hopping (filling prescriptions for the same benzodiazepine in different pharmacies within 7 days). There was a sudden, sustained reduction in benzodiazepine use in all the neighborhoods after the program's introduction. Despite the lowest rates of baseline use, enrollees in predominantly (> or = 75%) black neighborhoods experienced the highest rates of discontinuation after introduction of the program. This difference remained 7 years after policy initiation. Compared with white participants, black participants were more likely to discontinue nonproblema...Continue Reading

Citations

Apr 2, 2008·Psychiatric Services : a Journal of the American Psychiatric Association·Hui-wen Keri YangBruce Stuart
Jun 13, 2009·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Zoi TsimtsiouRoger Jones
Nov 17, 2009·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Hannah L F CooperDon C Des Jarlais
Jul 9, 2013·Annals of Epidemiology·Aletta DijkstraFanny Janssen
Mar 12, 2013·Social Science Quarterly·Molly J DingelBarbara A Koenig
Feb 22, 2011·Journal of Clinical Pharmacy and Therapeutics·J FisherI Sketris
May 15, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Bianca BlanchSallie-Anne Pearson
Sep 22, 2012·Pharmacoepidemiology and Drug Safety·Linda Simoni-Wastila, Jingjing Qian
Jun 27, 2019·Journal of General Internal Medicine·Lauren B GerlachDonovan T Maust
May 6, 2016·The Mental Health Clinician·Allison Schmitz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.